These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29550927)

  • 1. Cooperative electrogenic proton transport pathways in the plasma membrane of the proton-secreting osteoclast.
    Kuno M
    Pflugers Arch; 2018 Jun; 470(6):851-866. PubMed ID: 29550927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid-inducible proton influx currents in the plasma membrane of murine osteoclast-like cells.
    Kuno M; Li G; Moriura Y; Hino Y; Kawawaki J; Sakai H
    Pflugers Arch; 2016 May; 468(5):837-47. PubMed ID: 26843093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]Bafilomycin as a probe for the transmembrane proton channel of the osteoclast vacuolar H(+)-ATPase.
    Mattsson JP; Keeling DJ
    Biochim Biophys Acta; 1996 Apr; 1280(1):98-106. PubMed ID: 8634321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mathematical model of osteoclast acidification during bone resorption.
    Marcoline FV; Ishida Y; Mindell JA; Nayak S; Grabe M
    Bone; 2016 Dec; 93():167-180. PubMed ID: 27650914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular phosphates enhance activities of voltage-gated proton channels and production of reactive oxygen species in murine osteoclast-like cells.
    Li G; Miura K; Kuno M
    Pflugers Arch; 2017 Feb; 469(2):279-292. PubMed ID: 27999941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
    David P; Nguyen H; Barbier A; Baron R
    J Bone Miner Res; 1996 Oct; 11(10):1498-507. PubMed ID: 8889850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion channels and transporters in osteoclasts.
    Supanchart C; Kornak U
    Arch Biochem Biophys; 2008 May; 473(2):161-5. PubMed ID: 18406337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH dependence and inhibition by extracellular calcium of proton currents via plasmalemmal vacuolar-type H+-ATPase in murine osteoclasts.
    Sakai H; Kawawaki J; Moriura Y; Mori H; Morihata H; Kuno M
    J Physiol; 2006 Oct; 576(Pt 2):417-25. PubMed ID: 16901940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclastic acidification pathways during bone resorption.
    Rousselle AV; Heymann D
    Bone; 2002 Apr; 30(4):533-40. PubMed ID: 11934642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border.
    Baron R; Neff L; Louvard D; Courtoy PJ
    J Cell Biol; 1985 Dec; 101(6):2210-22. PubMed ID: 3905822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclastic acid transport: mechanism and implications for physiological and pharmacological regulation.
    Schlesinger PH; Mattsson JP; Blair HC
    Miner Electrolyte Metab; 1994; 20(1-2):31-9. PubMed ID: 8202050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and cellular distribution of the osteoclast ruffled membrane vacuolar H+-ATPase B-subunit using isoform-specific antibodies.
    Mattsson JP; Skyman C; Palokangas H; Väänänen KH; Keeling DJ
    J Bone Miner Res; 1997 May; 12(5):753-60. PubMed ID: 9144341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoclastic bone resorption by a polarized vacuolar proton pump.
    Blair HC; Teitelbaum SL; Ghiselli R; Gluck S
    Science; 1989 Aug; 245(4920):855-7. PubMed ID: 2528207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cytoplasmic pH in osteoclasts. Contribution of proton pumps and a proton-selective conductance.
    Nordström T; Rotstein OD; Romanek R; Asotra S; Heersche JN; Manolson MF; Brisseau GF; Grinstein S
    J Biol Chem; 1995 Feb; 270(5):2203-12. PubMed ID: 7836451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PMEPA1 and NEDD4 control the proton production of osteoclasts by regulating vesicular trafficking.
    Hirata H; Xu X; Nishioka K; Matsuhisa F; Kitajima S; Kukita T; Murayama M; Urano Y; Miyamoto H; Mawatari M; Kukita A
    FASEB J; 2021 Feb; 35(2):e21281. PubMed ID: 33484199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice.
    Nijenhuis T; van der Eerden BC; Hoenderop JG; Weinans H; van Leeuwen JP; Bindels RJ
    J Bone Miner Res; 2008 Nov; 23(11):1815-24. PubMed ID: 18597625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V-ATPase a3 Subunit in Secretory Lysosome Trafficking in Osteoclasts.
    Nakanishi-Matsui M; Matsumoto N
    Biol Pharm Bull; 2022; 45(10):1426-1431. PubMed ID: 36184499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application.
    Niikura K; Takeshita N; Takano M
    J Bone Miner Res; 2005 Sep; 20(9):1579-88. PubMed ID: 16059630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory mechanisms and physiological relevance of a voltage-gated H+ channel in murine osteoclasts: phorbol myristate acetate induces cell acidosis and the channel activation.
    Mori H; Sakai H; Morihata H; Kawawaki J; Amano H; Yamano T; Kuno M
    J Bone Miner Res; 2003 Nov; 18(11):2069-76. PubMed ID: 14606521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.
    Niikura K; Takano M; Sawada M
    Br J Pharmacol; 2004 Jun; 142(3):558-66. PubMed ID: 15148249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.